Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1989 Feb;57(2):338–343. doi: 10.1128/iai.57.2.338-343.1989

Induction of macrophage procoagulant activity by Bacteroides fragilis.

G A Rosenthal 1, G Levy 1, O D Rotstein 1
PMCID: PMC313102  PMID: 2643564

Abstract

Fibrin deposition in the peritoneal cavity during acute peritonitis appears to predispose the host to abscess formation by providing an environment for bacterial proliferation protected from host defenses. The purpose of the present study was to determine whether the potent abscess-inducing anaerobe Bacteroides fragilis could promote fibrin deposition by inducing mononuclear cells to express procoagulant activity (PCA). B. fragilis stimulated PCA in a dose-dependent fashion, achieving a maximum at 10(7) CFU/ml. Heat-killed B. fragilis induced comparable levels of PCA, while a nonspecific phagocytic stimulus, latex beads, was not stimulatory. B. fragilis was capable of inducing PCA even when phagocytosis was blocked by preexposure of cells to latex beads. The results suggested that phagocytosis was neither necessary nor sufficient for the generation of PCA. Cell separation studies showed that PCA was solely produced by macrophages and that lymphocytes did not augment its production. These studies suggest one potential mechanism by which B. fragilis might initiate abscess formation.

Full text

PDF
338

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abecassis M., Falk J. A., Makowka L., Dindzans V. J., Falk R. E., Levy G. A. 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest. 1987 Sep;80(3):881–889. doi: 10.1172/JCI113147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ahrenholz D. H., Simmons R. L. Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery. 1980 Jul;88(1):41–47. [PubMed] [Google Scholar]
  3. Bøyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol. 1976 Jun;Suppl 5:9–15. [PubMed] [Google Scholar]
  4. Chalkiadakis G., Kostakis A., Karayannacos P. E., Giamarellou H., Dontas I., Sakellariou I., Skalkeas G. D. The effect of heparin upon fibrinopurulent peritonitis in rats. Surg Gynecol Obstet. 1983 Sep;157(3):257–260. [PubMed] [Google Scholar]
  5. Chapman H. A., Jr, Vavrin Z., Hibbs J. B., Jr Coordinate expression of macrophage procoagulant and fibrinolytic activity in vitro and in vivo. J Immunol. 1983 Jan;130(1):261–266. [PubMed] [Google Scholar]
  6. Ciano P. S., Colvin R. B., Dvorak A. M., McDonagh J., Dvorak H. F. Macrophage migration in fibrin gel matrices. Lab Invest. 1986 Jan;54(1):62–70. [PubMed] [Google Scholar]
  7. Colvin R. B., Johnson R. A., Mihm M. C., Jr, Dvorak H. F. Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man. J Exp Med. 1973 Sep 1;138(3):686–698. doi: 10.1084/jem.138.3.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dunn D. L., Barke R. A., Ewald D. C., Simmons R. L. Macrophages and translymphatic absorption represent the first line of host defense of the peritoneal cavity. Arch Surg. 1987 Jan;122(1):105–110. doi: 10.1001/archsurg.1987.01400130111017. [DOI] [PubMed] [Google Scholar]
  9. Edwards R. L., Rickles F. R. The role of human T cells (and T cell products) for monocyte tissue factor generation. J Immunol. 1980 Aug;125(2):606–609. [PubMed] [Google Scholar]
  10. Geczy C. L., Roberts I. M., Meyer P., Bernard C. C. Susceptibility and resistance to experimental autoimmune encephalomyelitis and neuritis in the guinea pig correlate with the induction of procoagulant and anticoagulant activities. J Immunol. 1984 Dec;133(6):3026–3036. [PubMed] [Google Scholar]
  11. Hau T., Ahrenholz D. H., Simmons R. L. Secondary bacterial peritonitis: the biologic basis of treatment. Curr Probl Surg. 1979 Oct;16(10):1–65. doi: 10.1016/s0011-3840(79)80011-8. [DOI] [PubMed] [Google Scholar]
  12. Hau T., Simmons R. L. Heparin in the treatment of experimental peritonitis. Ann Surg. 1978 Mar;187(3):294–298. doi: 10.1097/00000658-197803000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Holdsworth S. R., Tipping P. G. Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit. J Clin Invest. 1985 Oct;76(4):1367–1374. doi: 10.1172/JCI112112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hopper K. E., Geczy C. L., Davies W. A. A mechanism of migration inhibition in delayed-type hypersensitivity reactions. I. Fibrin deposition on the surface of elicited peritoneal macrophages on vivo. J Immunol. 1981 Mar;126(3):1052–1058. [PubMed] [Google Scholar]
  15. Janco R. L., Morris P. J. Regulation of monocyte procoagulant by chemoattractants. Blood. 1985 Mar;65(3):545–552. [PubMed] [Google Scholar]
  16. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  17. Kasper D. L. Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis. J Infect Dis. 1976 Jul;134(1):59–66. doi: 10.1093/infdis/134.1.59. [DOI] [PubMed] [Google Scholar]
  18. Kasper D. L. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition. J Infect Dis. 1976 Jan;133(1):79–87. doi: 10.1093/infdis/133.1.79. [DOI] [PubMed] [Google Scholar]
  19. Lando P. A., Edgington T. S. Lymphoid procoagulant response to bacterial endotoxin in the rat. Infect Immun. 1985 Dec;50(3):660–666. doi: 10.1128/iai.50.3.660-666.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lantz M. S., Switalski L. M., Kornman K. S., Hök M. Bacteroides intermedius binds fibrinogen. J Bacteriol. 1985 Aug;163(2):623–628. doi: 10.1128/jb.163.2.623-628.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Levy G. A., Edgington T. S. Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med. 1980 May 1;151(5):1232–1244. doi: 10.1084/jem.151.5.1232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lyberg T., Prydz H. Phorbol esters induce synthesis of thromboplastin activity in human monocytes. Biochem J. 1981 Mar 15;194(3):699–706. doi: 10.1042/bj1940699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Maier R. V., Ulevitch R. J. The induction of a unique procoagulant activity in rabbit hepatic macrophages by bacterial lipopolysaccharides. J Immunol. 1981 Oct;127(4):1596–1600. [PubMed] [Google Scholar]
  24. Muhlfelder T. W., Niemetz J., Kreutzer D., Beebe D., Ward P. A., Rosenfeld S. I. C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation. J Clin Invest. 1979 Jan;63(1):147–150. doi: 10.1172/JCI109269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Namavar F., Verweij A. M., Bal M., van Steenbergen T. J., de Graaff J., MacLaren D. M. Effect of anaerobic bacteria on killing of Proteus mirabilis by human polymorphonuclear leukocytes. Infect Immun. 1983 Jun;40(3):930–935. doi: 10.1128/iai.40.3.930-935.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Onderdonk A. B., Kasper D. L., Cisneros R. L., Bartlett J. G. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis. 1977 Jul;136(1):82–89. doi: 10.1093/infdis/136.1.82. [DOI] [PubMed] [Google Scholar]
  27. Onderdonk A. B., Markham R. B., Zaleznik D. F., Cisneros R. L., Kasper D. L. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model. J Clin Invest. 1982 Jan;69(1):9–16. doi: 10.1172/JCI110445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Onderdonk A. B., Moon N. E., Kasper D. L., Bartlett J. G. Adherence of Bacteroides fragilis in vivo. Infect Immun. 1978 Mar;19(3):1083–1087. doi: 10.1128/iai.19.3.1083-1087.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Prydz H., Allison A. C. Tissue thromboplastin activity of isolated human monocytes. Thromb Haemost. 1978 Jun 30;39(3):582–591. [PubMed] [Google Scholar]
  30. Rothberger H., Zimmerman T. S., Spiegelberg H. L., Vaughan J. H. Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes. J Clin Invest. 1977 Mar;59(3):549–557. doi: 10.1172/JCI108670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rothberger H., Zimmerman T. S., Vaughan J. H. Increased production and expression of tissue thromboplastin-like procoagulant activity in vitro by allogeneically stimulated human leukocytes. J Clin Invest. 1978 Sep;62(3):649–655. doi: 10.1172/JCI109172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rotstein O. D., Kao J. Prevention of intra-abdominal abscesses by fibrinolysis using recombinant tissue plasminogen activator. J Infect Dis. 1988 Oct;158(4):766–772. doi: 10.1093/infdis/158.4.766. [DOI] [PubMed] [Google Scholar]
  33. Rotstein O. D., Pruett T. L., Simmons R. L. Fibrin in peritonitis. V. Fibrin inhibits phagocytic killing of Escherichia coli by human polymorphonuclear leukocytes. Ann Surg. 1986 Apr;203(4):413–419. doi: 10.1097/00000658-198604000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schwartz B. S., Levy G. A., Fair D. S., Edgington T. S. Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J Exp Med. 1982 May 1;155(5):1464–1479. doi: 10.1084/jem.155.5.1464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Semeraro N., Biondi A., Lorenzet R., Locati D., Mantovani A., Donati M. B. Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. Immunology. 1983 Dec;50(4):529–535. [PMC free article] [PubMed] [Google Scholar]
  36. Shands J. W., Jr Lymphocyte collaboration is not required for the induction of murine macrophage procoagulant by endotoxin. Thromb Res. 1987 Apr 15;46(2):271–279. doi: 10.1016/0049-3848(87)90289-1. [DOI] [PubMed] [Google Scholar]
  37. Shapiro M. E., Kasper D. L., Zaleznik D. F., Spriggs S., Onderdonk A. B., Finberg R. W. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. J Immunol. 1986 Jul 1;137(1):341–346. [PubMed] [Google Scholar]
  38. Simon G. L., Klempner M. S., Kasper D. L., Gorbach S. L. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide. J Infect Dis. 1982 Jan;145(1):72–77. doi: 10.1093/infdis/145.1.72. [DOI] [PubMed] [Google Scholar]
  39. Steffen E. K., Hentges D. J. Hydrolytic enzymes of anaerobic bacteria isolated from human infections. J Clin Microbiol. 1981 Aug;14(2):153–156. doi: 10.1128/jcm.14.2.153-156.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tally F. P., Goldin B. R., Jacobus N. V., Gorbach S. L. Superoxide dismutase in anaerobic bacteria of clinical significance. Infect Immun. 1977 Apr;16(1):20–25. doi: 10.1128/iai.16.1.20-25.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wollenweber H. W., Rietschel E. T., Hofstad T., Weintraub A., Lindberg A. A. Nature, type of linkage, quantity, and absolute configuration of (3-hydroxy) fatty acids in lipopolysaccharides from Bacteroides fragilis NCTC 9343 and related strains. J Bacteriol. 1980 Dec;144(3):898–903. doi: 10.1128/jb.144.3.898-903.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. ZINSSER H. H., PRYDE A. W. Experimental study of physical factors, including fibrin formation, influencing the spread of fluids and small particles within and from the peritoneal cavity of the dog. Ann Surg. 1952 Nov;136(5):818–827. doi: 10.1097/00000658-195211000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Zaleznik D. F., Finberg R. W., Shapiro M. E., Onderdonk A. B., Kasper D. L. A soluble suppressor T cell factor protects against experimental intraabdominal abscesses. J Clin Invest. 1985 Mar;75(3):1023–1027. doi: 10.1172/JCI111763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Zaleznik D. F., Zhang Z. L., Onderdonk A. B., Kasper D. L. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide. J Infect Dis. 1986 Jul;154(1):40–46. doi: 10.1093/infdis/154.1.40. [DOI] [PubMed] [Google Scholar]
  45. van Ginkel C. J., Thörig L., Thompson J., Oh J. I., van Aken W. G. Enhancement of generation of monocyte tissue thromboplastin by bacterial phagocytosis: possible pathway for fibrin formation on infected vegetations in bacterial endocarditis. Infect Immun. 1979 Jul;25(1):388–395. doi: 10.1128/iai.25.1.388-395.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES